motherlodetv.net
As well as yesterday’s announcement of a collaboration with Solarvest BioEnergy Inc to research using its algal expression technology to develop pharmaceutical-grade cannabinoids, FSD Pharma (CSE.HUGE) is also involved with Aura Health Inc. (CSE:BUZZ). This collaboration will give FSD Pharma a window into the medical marijuana market in Germany and, eventually, the EU generally.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or “FSD”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”), a technology company that developed an algal-based flexible production platform capable of producing health products, announced today that they signed a definitive collaborative research and development agreement. Under the agreement, Solarvest will conduct research using its algal expression technology to develop pharmaceutical-grade cannabinoids. FSD Pharma and Solarvest have made investments into one another and FSD has the option to enter into an exclusive license arrangement over a subset of the project and receive royalty rights over all of the products that result from the project.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma”, “FSD” or “the Company”) today reported its financial and operational results for the fourth quarter and fiscal year-ended December 31, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.
World Class Extractions Inc. (CSE: PUMP) (“World Class” or the “Company”) would like to congratulate Quadron Cannatech Corporation (“Quadron”) on its introduction of the Big BOSS, the latest model of Quadron’s automated, next generation hemp and cannabis extraction system. According to Quadron’s press release dated May 1, 2019, the Big BOSS provides the same advantages as the distinguished BOSS, but with significantly larger processing capabilities. The Big Boss is capable of processing up to 3,000 lb biomass per day, which translates to 66,000 lbs biomass processing per month (based on operating the Big BOSS 5 days per week), and nearly 800,000 lbs biomass processing per year.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that it has entered into a share exchange transaction with Aura Health Inc. (“Aura”). Pursuant to the agreement, FSD acquired 13,562,386 Aura shares valued at $3 million issued from treasury in exchange for 13,181,019 FSD shares issued from treasury valued at $3 million. Aura Health is a Toronto-based cannabis company building an international network of vertically integrated businesses in the medical cannabis industry.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company, announced today that they have entered into a securities exchange agreement dated April 22, 2019 (the “Agreement”) pursuant to which FSD Pharma has agreed to acquire all of the outstanding securities of Prismic (the “Transaction”). Prismic is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s (“PEA”) “entourage” effect on certain drugs impacting the endocannabinoid system.
Anthony Durkacz has a unique perspective on Canada’s emerging cannabis industry. Through his First Republic Capital, he has financed FSD Pharma (C.HUGE), Canntab Therapeutics (C.PILL), Cannara Biotech (C.LOVE) and, now, World-Class Extractions (C.PUMP). In each case Durkacz has been looking for business models which go well beyond the simple cultivation of cannabis.
I have an article up about FSD Pharma (C.HUGE) getting its medical sales licence up at Seeking Alpha.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019.
World Class Extractions Inc. (CSE: PUMP) (“World Class” or the “Company“) is pleased to announce that it has retained the services of Mackie Research Capital Corporation (“Mackie Research“) to act as financial advisor to the Company.